New scan could reveal how liver tumors respond to chemo
NCT ID NCT04796818
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study is testing a special type of MRI scan to see if it can better measure how colorectal cancer liver tumors respond to chemotherapy. About 70 people with liver metastases that have not been treated yet will get the scan before and after chemo. The goal is to improve how doctors track treatment response, not to provide a new treatment itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new blood test spot colorectal cancer return earlier?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Experimental drug combo targets Hard-to-Treat GI cancers
- Double immunotherapy plus liver blockade targets eye cancer that spreads
- Wheat germ supplement studied for immune boost in advanced cancer
- Could a pill help the liver regrow and make more cancer surgeries possible?